KETV Omaha16h
FDA approves weight-loss drug Zepbound for obstructive sleep apnea
Treatment with Zepbound, whose generic name is tirzepatide, led to improvements in both sets of patients, according to ...
FDA: Weight loss drug Zepbound, diabetes drug Mounjaro no longer in shortage
Consumers who take copies of the weight loss drug Zepbound and diabetes drug Mounjaro will need to find a new source for ...
The FDA says the Zepbound shortage is over. That's rattling the weight loss industry
The U.S. Food and Drug Administration announced Thursday that the shortage of tirzepatide — the active ingredient in Eli ...
Novo Nordisk’s next-generation weight-loss drug matches Lilly’s Zepbound in major trial, but doesn’t surpass it
Novo Nordisk’s latest attempt in weight loss, a combination drug called CagriSema, matched the bar set by Lilly’s currently ...
FDA Says Shortage of Eli Lilly’s Zepbound Is Over, but Gives Compounders a Grace Period
The Food and Drug Administration said Thursday that the longstanding shortage of Eli Lilly’s weight-loss drug Zepbound and ...
MedPage Today3d
FDA Says Compounded Tirzepatide Must Exit the Market
Approved in 2022 for type 2 diabetes and in 2023 for chronic weight management along with diet and exercise, tirzepatide is ...
Hosted on MSN3d
FDA Says Shortage of GLP-1 Tirzepatide Is Over
The U.S. Food and Drug Administration re-issued a decision first made by the agency in October that a shortage of the ...
A millionaire tech 'biohacker' is microdosing Zepbound to stay young
Bryan Johnson, the tech entrepreneur and millionaire who became famous for infusing his son’s plasma into his blood in an ...